Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02247765
Recruitment Status : Completed
First Posted : September 25, 2014
Results First Posted : May 5, 2017
Last Update Posted : May 5, 2017
Sponsor:
Information provided by (Responsible Party):
Medtronic - MITG

Brief Summary:
To validate the proposed claims for pulse rate and saturation accuracy in a diverse subject population during motion over a specified saturation range.

Condition or disease Intervention/treatment Phase
Healthy Hypoxia Device: Arterial line Device: Motion Phase 3

Detailed Description:
Use an investigational oximetry system to evaluate the triggering of the "sensor off" status with marketed, off-the-shelf sensors.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples During Motion in Healthy, Well Perfused Subjects With the USB Pulse Oximetry Monitor Interface Cable
Study Start Date : November 2014
Actual Primary Completion Date : November 2014
Actual Study Completion Date : December 2014

Arm Intervention/treatment
Experimental: Arterial Line
CO-Oximetry value obtained as a comparator. Obtained during motion conditions.
Device: Arterial line
Arterial line is inserted to draw a CO-Oximeter value as it is the gold standard and as advised in ISO 80601
Other Name: CO-Oximeter SaO2 value

Experimental: Motion
The subject has to perform motions during the procedure. This is to verify that device is able to read through motion.
Device: Motion
The subject is asked to move their hand by either rubbing or tapping their fingers at a specified frequency and amplitude during portions of the hypoxic procedure.




Primary Outcome Measures :
  1. SpO2 Accuracy During Motion Conditions - MaxA Sensor [ Time Frame: up to 6 months ]
    For each range specified, SpO2 accuracy of the pulse oximeter equipment is stated in terms of the Accuracy Root‐Mean‐Square (ARMS) difference between measured values (SpO2) and reference blood values (SaO2). The MaxA sensors has a different bandage from the MaxN sensor, and therefore a different form and fit.

  2. SpO2 Accuracy During Motion Conditions - MaxN Sensor [ Time Frame: up to 6 months ]
    For each range specified, SpO2 accuracy of the pulse oximeter equipment is stated in terms of the Accuracy Root‐Mean‐Square (ARMS) difference between measured values (SpO2) and reference blood values (SaO2). The MaxN sensor has a different bandage from the MaxA sensor, and therefore a different form and fit.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male or female of any race
  • 18-50 years old, inclusive
  • Females: negative urine pregnancy test on the day of study participation (prior to exposure to hypoxia)
  • Completed within the last year: physical exam by a licensed physician, physician assistant (PA), or advanced practice nurse; including a 12 lead ECG, a medical history, and blood test (complete blood count and sickle cell trait/disease screening)
  • Meets specific demographic requirements for the monitoring device under study
  • Willing and able to provide written informed consent
  • Able to participate for the duration of the evaluation

Exclusion Criteria:

  • A room-air baseline % modulation < 1.5% on all four fingers on the test hand
  • Under 18 years or over 50 years of age
  • Pregnant and/or lactating women
  • Hypertension: on three consecutive readings, systolic pressure greater than 145 mm Hg or diastolic pressure greater than 90 mm Hg
  • Ventricular premature complexes (VPC's) that are symptomatic or occur at a rate of more than four per minute
  • History of seizures (except childhood febrile seizures) or epilepsy
  • History of unexplained syncope
  • Daily or more frequent use of anxiolytic drugs (benzodiazepines) for treatment of anxiety disorder
  • Recent history of frequent migraine headaches: average of two or more per month over the last year
  • Compromised circulation, injury, or physical malformation of fingers, toes, hands, ears or forehead/skull or other sensor sites which would limit the ability to test sites needed for the study. (Note: Certain malformations may still allow subjects to participate if the condition is noted and would not affect the particular sites utilized.)
  • History of acute altitude sickness at or below moderate elevation (up to 5,000-10,000 feet) defined as three or more of the following symptoms: moderate to severe headache, general malaise, dizziness/lightheadedness, nausea/vomiting, fatigue/weakness, shortness of breath, nosebleed, persistent rapid pulse, or peripheral edema
  • History of significant respiratory disease such as severe asthma or emphysema or sleep apnea
  • Sickle cell disease or trait
  • Clinically significant abnormal finding on medical history, physical examination, clinical laboratory test or ECG. Clinical significance will be assessed by the principal investigator or study physician as designated.
  • History of stroke, transient ischemic attack or carotid artery disease
  • History of myocardial ischemia, angina, myocardial infarction, congestive heart failure or cardiomyopathy
  • History of chronic renal impairment
  • Severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors, ECG electrodes, respiration monitor electrodes or other medical sensors
  • Unwillingness or inability to remove colored nail polish or artificial nails from test digit(s)
  • Unwillingness or inability to give informed consent
  • Prior or known allergies to: lidocaine (or similar pharmacological agents, e.g., Novocain) or heparin
  • Recent arterial cannulation (i.e., less than 30 days prior to study date)
  • Six or more arterial cannulations of each (right & left) radial artery
  • History of clinically significant complications from previous arterial cannulation
  • Current use of blood thinners: prescription or daily aspirin use
  • History of bleeding disorders or personal history of prolonged bleeding from injury.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02247765


Locations
Layout table for location information
United States, Colorado
Boulder Clinical Laboratory
Boulder, Colorado, United States, 80301
Covidien RMS
Boulder, Colorado, United States, 80301
Sponsors and Collaborators
Medtronic - MITG
Investigators
Layout table for investigator information
Principal Investigator: Eric Heyer, MD Medtronic - MITG

Layout table for additonal information
Responsible Party: Medtronic - MITG
ClinicalTrials.gov Identifier: NCT02247765     History of Changes
Other Study ID Numbers: COVMOPR0445
First Posted: September 25, 2014    Key Record Dates
Results First Posted: May 5, 2017
Last Update Posted: May 5, 2017
Last Verified: March 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypoxia
Signs and Symptoms, Respiratory
Signs and Symptoms